The morbidity and mortality caused by invasive fungal infections are increasing across the
globe due to developments in transplant surgery, the use of immunosuppressive agents …

Fungal infections impact the lives of at least 12 million people every year, killing over 1.5
million. Wide-spread use of fungicides and prophylactic antifungal therapy have driven …

The rapid rise of bacterial resistance to traditional antibiotics combined with the decline in
discovery of novel antibacterial agents has created a global public health crisis …

Candida albicans is a successful colonizer of the human host, which can, under certain
circumstances cause a range of clinically diverse infections. Important virulence-associated …

Fungal infections are estimated to be responsible for 1.5 million deaths annually. Global anti-
microbial resistance is also observed for fungal pathogens, and scientists are looking for …

Background Lovastatin is one of the first statins to be extensively used for its cholesterol-
lowering ability. It is commercially produced by fermentation. Species belonging to the …

The fungus Aspergillus (A.) terreus has dominated the biological production of the
“blockbuster” drugs known as statins. The statins are a class of drugs that inhibit HMG-CoA …

The medical importance of intra-abdominal candidiasis (IAC) contrasts with the limited
number of pharmacological treatment options available and the increasing rate of resistance …

Statins are medications administered orally and are widely used for lowering the blood
cholesterol level. The aim of this study was to investigate the effects of orally administered …

Cryptococcosis caused by Cryptococcus gattii leads to pneumonia and
meningoencephalitis, and has a high mortality rate worldwide due to the inadequacy of …